Concentrations of the Stress Hormone Copeptin Increase upon Hypoglycaemia in Patients with Type 1 Diabetes Dependent of Hypoglycaemia Awareness

被引:12
|
作者
Seelig, Eleonora [1 ]
Bilz, Stefan [2 ]
Keller, Ulrich [1 ]
Meienberg, Fabian [1 ]
Christ-Crain, Mirjam [1 ]
机构
[1] Univ Basel Hosp, Dept Diabetol Endocrinol & Metab, CH-4031 Basel, Switzerland
[2] Kantonsspital, Dept Endocrinol, St Gallen, Switzerland
来源
PLOS ONE | 2013年 / 8卷 / 08期
关键词
INSULIN-INDUCED HYPOGLYCEMIA; ARGININE-VASOPRESSIN; STABLE PEPTIDE; PRECURSOR; PLASMA; SECRETION; RESPONSES; FAILURE; ASSAY;
D O I
10.1371/journal.pone.0072876
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Copeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after transsphenoidal surgery of pituitary adenomas. Patients with type 1 diabetes mellitus are prone to hypoglycaemia, but no data about copeptin levels upon hypoglycaemia are available. Furthermore, the perception of hypoglycaemia can vary from total unawareness to disabling episodes. The aim of this study was to investigate whether copeptin increases upon hypoglycaemia in patients with type 1 diabetes mellitus and is associated with the degree of hypoglycaemia awareness. Materials and Methods: In this prospective observational study, 17 patients with type 1 diabetes underwent a standardized insulin infusion test. Blood sampling for glucose and copeptin was performed at baseline and after 60 minutes (min). To assess hypoglycaemia associated symptoms the Mood and Symptom Questionnaire (MSQ) was conducted at baseline and after 60 min. Results: During insulin infusion, blood glucose decreased from 5.1 (SD +/- 0.2) to 3.0 (+/- 0.5) mmol/L at 60 min (p<0.001). Copeptin concentrations increased from 3.2 (+/- 1.7) to 3.8 (+/- 1.9) pmol/L (p = 0.03). Mood and Symptoms Questionnaire scores increased from 14 (+/- 3.0) to 18 (+/- 5.8), (p = 0.006). Patients with good hypoglycaemia awareness had an increase in copeptin from 3.0 (+/- 1.8) to 4.2 (+/- 2.4) pmol/L (p = 0.03) in contrast to patients more unaware of hypoglycaemia who only showed an increase in copeptin from 3.3 (+/- 1.6) to 3.6 (+/- 1.4) pmol/L (p = 0.4). There was a trend to a larger copeptin increase in patients aware of hypoglycemia compared to patients unaware of hypoglycemia (p = 0.074). Conclusion: Copeptin increases in patients with type 1 diabetes upon insulin induced hypoglycaemia. Interestingly, the copeptin increase seems associated with the degree of hypoglycaemia awareness. This hypothesis warrants further verification.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Ole Elvebakk
    Christian Tronstad
    Kåre I. Birkeland
    Trond G. Jenssen
    Marit R. Bjørgaas
    Kathrine F. Frøslie
    Kristin Godang
    Håvard Kalvøy
    Ørjan G. Martinsen
    Hanne L. Gulseth
    Scientific Reports, 8
  • [32] Cardiac autonomic regulation during experimental hypoglycaemia in Type 1 diabetes with impaired awareness of hypoglycaemia (IAH)
    Walkinshaw, E.
    Little, S. A.
    Bernjak, A.
    Lubina-Solomon, A.
    Chow, E.
    Shaw, J. A.
    Heller, S. R.
    DIABETIC MEDICINE, 2015, 32 : 61 - 61
  • [33] Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Elvebakk, Ole
    Tronstad, Christian
    Birkeland, Kare I.
    Jenssen, Trond G.
    Bjorgaas, Marit R.
    Froslie, Kathrine F.
    Godang, Kristin
    Kalvoy, Havard
    Martinsen, Orjan G.
    Gulseth, Hanne L.
    SCIENTIFIC REPORTS, 2018, 8
  • [34] Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes
    Bahrami, Jasmine
    Tomlinson, George
    Murphy, Helen R.
    Feig, Denice S.
    DIABETIC MEDICINE, 2022, 39 (05)
  • [35] Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on inflammatory profile in people with type 1 diabetes
    Ali, N.
    Janssen, A. W. M.
    De Galan, B. E.
    Tack, C. J.
    Jaeger, M.
    Van de Wijer, L.
    van der Heijden, W.
    ter Horst, R.
    Vart, P.
    van Gool, A.
    Joosten, L. A. B.
    Netea, M. G.
    Stienstra, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S96 - S96
  • [36] The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes
    Joel T. Dunn
    Pratik Choudhary
    Ming Ming Teh
    Ian Macdonald
    Katharine F. Hunt
    Paul K. Marsden
    Stephanie A. Amiel
    Diabetologia, 2018, 61 : 1676 - 1687
  • [37] Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin
    Ferguson, SC
    Strachan, MWJ
    Janes, JM
    Frier, BM
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2001, 17 (04) : 285 - 291
  • [38] Prevalence and risk factors of hypoglycaemia unawareness and severe hypoglycaemia in patients with type 1 diabetes
    A'Campo, T.
    Schouwenberg, B.
    Veldman, B.
    Tack, C. J.
    Smits, P.
    De Galan, B. E.
    DIABETOLOGIA, 2010, 53
  • [39] Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetes
    Tor I. Hansen
    Sandra E. Olsen
    Elise C. D. Haferstrom
    Trond Sand
    Brian M. Frier
    Asta K. Håberg
    Marit R. Bjørgaas
    Diabetologia, 2017, 60 : 971 - 979
  • [40] Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetes
    Hansen, Tor I.
    Olsen, Sandra E.
    Haferstrom, Elise C. D.
    Sand, Trond
    Frier, Brian M.
    Haberg, Asta K.
    Bjorgaas, Marit R.
    DIABETOLOGIA, 2017, 60 (06) : 971 - 979